Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $27.98 USD
Change Today -0.22 / -0.78%
Volume 429.5K
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

cardiovascular systems inc (CSII) Snapshot

Open
$28.10
Previous Close
$28.20
Day High
$28.49
Day Low
$27.21
52 Week High
04/10/15 - $41.28
52 Week Low
10/1/14 - $23.15
Market Cap
887.2M
Average Volume 10 Days
355.6K
EPS TTM
$-1.08
Shares Outstanding
31.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOVASCULAR SYSTEMS INC (CSII)

cardiovascular systems inc (CSII) Related Bloomberg News

View More Bloomberg News

cardiovascular systems inc (CSII) Related Businessweek News

No Related Businessweek News Found

cardiovascular systems inc (CSII) Details

Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and markets devices for the treatment of vascular diseases. Its products include catheter-based platforms, such as the Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The company markets its products through direct sales force to hospitals and office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

479 Employees
Last Reported Date: 08/28/14
Founded in 1989

cardiovascular systems inc (CSII) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.1M
Chief Financial Officer
Total Annual Compensation: $330.7K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $305.4K
Chief Healthcare Policy Officer
Total Annual Compensation: $318.7K
Chief Administrative Officer, Compliance Offi...
Total Annual Compensation: $296.4K
Compensation as of Fiscal Year 2014.

cardiovascular systems inc (CSII) Key Developments

Cardiovascular Systems Inc. Approves Amendments to Article III, Section 8 of its Amended and Restated Bylaws

On May 19, 2015, the Board of Directors of Cardiovascular Systems Inc. approved an amendment to Article III, Section 8 of the company's amended and restated Bylaws to establish majority voting for the election of directors in uncontested elections. In general, the amendment provides that directors will be elected by a majority of the votes cast by the shares present at a meeting and entitled to vote on the election of directors, however, that in the case of a contested election, directors will continue to be elected by a plurality of the votes present at the meeting and entitled to vote on the election of directors. The Board also approved an amendment to its Principles of Corporate Governance to accompany the amendment to the Amended and Restated Bylaws.

Cardiovascular Systems Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 04:50 PM

Cardiovascular Systems Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 04:50 PM. Venue: Loews Minneapolis Hotel, 601, 1st Ave North, Minneapolis, MN 55403, United States. Speakers: David L Martin, CEO.

Cardiovascular Systems Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015; Provides Earnings Guidance for the Fourth Quarter Ending June 30, 2015

Cardiovascular Systems Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported revenues of $47,004,000 compared to $34,945,000 a year ago. Loss from operations was $10,543,000 compared to $9,593,000 a year ago. Net loss was $10,656,000 or $0.34 per basic and diluted share compared to $9,712,000 or $0.32 per basic and diluted share a year ago. Adjusted LBITDA was $6,004,000 compared to $6,413,000 a year ago. The improvement was driven by a higher level of stock compensation expense. Net loss increased from the prior year primarily due to planned investments, including sales force expansion and coronary product commercialization. Cash usage in the quarter of $8 million included about $5 million of property and equipment primarily for new facility in Minnesota. For the nine months period, the company reported revenues of $133,090,000 compared to $97,048,000 a year ago. Loss from operations was $23,985,000 compared to $23,935,000 a year ago. Net loss was $24,153,000 or $0.77 per basic and diluted share compared to $25,662,000 or $0.94 per basic and diluted share a year ago. Adjusted LBITDA was $11,529,000 compared to $15,271,000 a year ago. For the fiscal 2015 fourth quarter ending June 30, 2015, the company anticipates revenue growth of 24% to 28% over the fourth quarter of fiscal 2014, to a range of $49.0 million to $50.5 million; gross profit as a percentage of revenues approximately 50 basis points higher than the third quarter of fiscal 2015. Net loss expects to be in the range of $9.0 million to $10.0 million, or loss per common share ranging from $0.28 to $0.31, assuming 31.8 million average shares outstanding.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSII:US $27.98 USD -0.22

CSII Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $22.94 USD +0.35
CryoLife Inc $10.71 USD -0.15
Endologix Inc $16.69 USD +0.10
Spectranetics Corp/The $24.83 USD +0.83
Vascular Solutions Inc $32.63 USD -0.09
View Industry Companies
 

Industry Analysis

CSII

Industry Average

Valuation CSII Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.1x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOVASCULAR SYSTEMS INC, please visit www.csi360.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.